Emerging markets hold promise for pharma sales

08/24/2010 | Economic Times (India), The

Drugmaker Lupin expects sales in emerging markets to equal sales in the U.S. and Japan, combined, by 2018. The company plans to expand operations in Brazil and Mexico, where it sees opportunity in gynecology, cardiology, oral contraceptives and biotechnology markets.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park